| Sign In to gain access to subscriptions and/or personal tools. |
The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositisDivision of Rheumatology and Clinical Immunology, Spedali Civili, Brescia, Italy; Servizio di Reumatologia ed Immunologia Clinica, Spedali Civili, Piazzale Spedali Civili, I-25124 Brescia, Italycattaneo{at}master.cci.unibs.it
Division of Rheumatology and Clinical Immunology, Spedali Civili, Brescia, Italy
Division of Gynecology and Obstetrics, Spedali Civili, Brescia, Italy
Division of Neonatology, Spedali Civili, Brescia, Italy
Division of Gynecology and Obstetrics, Spedali Civili, Brescia, Italy
Division of Rheumatology and Clinical Immunology, Spedali Civili, Brescia, Italy The case of a woman affected by an overlap syndrome systemic lupus erythematosus/polymyositis (PM), who presented with active myositis at the start of the pregnancy, is reported. Therapy with cyclosporin, corticosteroids, hydroxychloroquine and high-dose intravenous immunoglobulin induced a progressive remission of clinical and laboratory signs of myositis. At 33 weeks of gestation, after a premature pre-term rupture of membrane, a male child was delivered. Although premature, and small for gestational age, he had a normal growth, and did not show any clinical sign suggestive of immune deficiency. Lymphocyte phenotypical and functional studies, as well as response to vaccination, were also normal.
Key Words: cyclosporin newborn polymyositis pregnancy SLE
Lupus, Vol. 11, No. 7,
454-457 (2002) This article has been cited by other articles:
|
|||||||||||||||||||||||||||
